Matching for the nonconventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GVHD.
暂无分享,去创建一个
H. Inoko | M. Labopin | I. Yakoub-Agha | D. Blaise | A. Nagler | M. Mohty | F. Claas | B. van der Holt | P. Moreau | A. Toubert | A. Schmitt-Graeff | S. Bahram | J. Cornelissen | F. Ciceri | R. Carapito | R. Tamouza | M. Ota | Y. Katsuyama | G. Socié | D. Charron | A. Cesbron | K. Gagne | M. Maumy-Bertrand | F. Bertrand | N. Milpied | P. A. von dem Borne | S. Querol | V. Dubois | K. Fleischhauer | M. Oudshoorn | C. Picard | C. Paillard | P. Loiseau | L. Vago | R. Zeiser | M. Untrau | J. Sierra | B. Lioure | M. Labalette | M. Michallet | J. Kuball | R. Peffault de Latour | N. Jung | M. Kwemou | S. Michel | A. Pichot | G. Giacometti | C. Macquin | W. Ilias | A. Morlon | I. Kotova | P. Apostolova | E. Spierings | A. Parissiadis | X. Lafarge | F. Claas | J. Kuball | J. Sierra | Annette Schmitt-Graeff | Gaëlle Giacometti | Cécile Macquin | Aurore Morlon
[1] P. Neiman,et al. CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S , 1974, Transplantation.
[2] A. Rimm,et al. Graft-versus-leukemia reactions after bone marrow transplantation. , 1990, Blood.
[3] D. Geraghty,et al. A second lineage of mammalian major histocompatibility complex class I genes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[4] L. Laloux,et al. Allelic repertoire of the human MHC class I MICA gene. , 1996, Immunogenetics.
[5] Takato O. Yoshida,et al. EFFECT OF MATCHING OF CLASS I HLA ALLELES ON CLINICAL OUTCOME AFTER TRANSPLANTATION OF HEMATOPOIETIC STEM CELLS FROM AN UNRELATED DONOR , 1998 .
[6] L. Laloux,et al. MICA haplotypic diversity , 1999, Immunogenetics.
[7] N. Shastri,et al. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages , 2000, Nature Immunology.
[8] T. Mcclanahan,et al. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. , 2000, Immunity.
[9] L. Lanier,et al. Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family , 2001, Immunogenetics.
[10] Katia Perruccio,et al. Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants , 2002, Science.
[11] F. Appelbaum,et al. Thomas' hematopoietic cell transplantation , 2003 .
[12] D. Blaise,et al. HLA Association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[13] N. Brousse,et al. Induction of NKG2D ligands by gamma radiation and tumor necrosis factor-alpha may participate in the tissue damage during acute graft-versus-host disease. , 2008, Transplantation.
[14] Mei-Jie Zhang,et al. Flexible competing risks regression modeling and goodness-of-fit , 2008, Lifetime data analysis.
[15] E. Petersdorf. Optimal HLA matching in hematopoietic cell transplantation. , 2008, Current opinion in immunology.
[16] Mei-Jie Zhang,et al. Predicting cumulative incidence probability by direct binomial regression , 2008 .
[17] Jeffrey S. Miller,et al. Limited role of MHC class I chain-related gene A (MICA) typing in assessing graft-versus-host disease risk after fully human leukocyte antigen-matched unrelated donor transplantation. , 2009, Blood.
[18] A. Toubert,et al. MICA-129 genotype, soluble MICA, and anti-MICA antibodies as biomarkers of chronic graft-versus-host disease. , 2009, Blood.
[19] E. Holler,et al. Graft-versus-host disease , 2009, The Lancet.
[20] S. Parmar,et al. Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease. , 2009, Blood.
[21] R. Brand,et al. Risk score for outcome after allogeneic hematopoietic stem cell transplantation , 2009, Cancer.
[22] Y. Kodera,et al. Worldwide network for blood and marrow transplantation , 2009 .
[23] J. Madrigal,et al. The impact of HLA genotyping on survival following unrelated donor haematopoietic stem cell transplantation , 2010, British journal of haematology.
[24] Michael Boeckh,et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. , 2010, The New England journal of medicine.
[25] R. Strong,et al. Crystal structure of a γδ T-cell receptor specific for the human MHC class I homolog MICA , 2011, Proceedings of the National Academy of Sciences.
[26] Jason Fine,et al. Competing Risks Regression for Stratified Data , 2011, Biometrics.
[27] Mei-Jie Zhang,et al. Analyzing Competing Risk Data Using the R timereg Package. , 2011, Journal of statistical software.
[28] H. Deeg,et al. A disease risk index for patients undergoing allogeneic stem cell transplantation. , 2012, Blood.
[29] P. Westervelt,et al. Peripheral-blood stem cells versus bone marrow from unrelated donors. , 2012, The New England journal of medicine.
[30] L. Zhao,et al. Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT. , 2012, Blood.
[31] Bruce R. Blazar,et al. Advances in graft-versus-host disease biology and therapy , 2012, Nature Reviews Immunology.
[32] Effie W Petersdorf,et al. Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study. , 2012, The Lancet. Oncology.
[33] E. Petersdorf. The major histocompatibility complex: a model for understanding graft-versus-host disease. , 2013, Blood.
[34] J. Maciejewski,et al. Synergistic effect of major histocompatibility complex class I-related chain a and human leukocyte antigen-DPB1 mismatches in association with acute graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[35] C. Müller,et al. The Impact of HLA-C Matching on Donor Identification Rates in a European-Caucasian Population , 2014, Front. Immunol..
[36] E. Spierings. Minor histocompatibility antigens: past, present, and future. , 2014, Tissue antigens.
[37] J. Ritz,et al. Current issues in chronic graft-versus-host disease. , 2014, Blood.
[38] J. Tiercy. HLA-C Incompatibilities in Allogeneic Unrelated Hematopoietic Stem Cell Transplantation , 2014, Front. Immunol..
[39] L. Andresen,et al. N-Glycosylation of Asparagine 8 Regulates Surface Expression of Major Histocompatibility Complex Class I Chain-related Protein A (MICA) Alleles Dependent on Threonine 24* , 2014, The Journal of Biological Chemistry.
[40] S. Forman,et al. Hematopoietic Cell Transplantation , 2015 .
[41] K. Fleischhauer. Immunogenetics of HLA-DP--A New View of Permissible Mismatches. , 2015, The New England journal of medicine.
[42] Karl Frauendorfer,et al. One million haemopoietic stem-cell transplants: a retrospective observational study. , 2015, The Lancet. Haematology.
[43] Martin Maiers,et al. The impact of amino acid variability on alloreactivity defines a functional distance predictive of permissive HLA-DPB1 mismatches in hematopoietic stem cell transplantation. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[44] H. Baker. High HLA-DP expression and graft-versus-host disease. , 2015, The Lancet. Oncology.
[45] T. Kambayashi,et al. NKG2D expression by CD8+ T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCT. , 2015, Blood.
[46] E. Petersdorf. HLA mismatching in transplantation. , 2015, Blood.
[47] S. Bahram,et al. Genetics, genomics, and evolutionary biology of NKG2D ligands , 2015, Immunological reviews.
[48] H. Bickeböller,et al. The MICA-129 dimorphism affects NKG2D signaling and outcome of hematopoietic stem cell transplantation , 2015, EMBO molecular medicine.
[49] H. Sengeløv,et al. The Role of Gamma Delta T Cells in Haematopoietic Stem Cell Transplantation , 2015, Scandinavian journal of immunology.
[50] A. Dreher. Modeling Survival Data Extending The Cox Model , 2016 .